158 related articles for article (PubMed ID: 23565126)
1. Development of treatment and clinical results in childhood acute myeloid leukemia in Poland.
Balwierz W; Pawinska-Wasikowska K; Klekawka T; Czogala M; Matysiak M; Fic-Sikorska B; Adamkiewicz-Drozynska E; Maciejka-Kapuscinska L; Chybicka A; Potocka K; Wachowiak J; Skalska-Sadowska J; Kowalczyk J; Wojcik B; Wysocki M; Koltan S; Krawczuk-Rybak M; Muszynska-Roslan K; Mlynarski W; Stolarska M; Urasinski T; Kamienska E; Szczepanski T; Tomaszewska R; Sobol G; Mizia-Malarz A; Karolczyk G; Podhorecka J; Wieczorek M; Karpinska-Derda I; Badowska W; Moryl-Bujakowska A
Memo; 2013 Feb; 6(1):54-62. PubMed ID: 23565126
[TBL] [Abstract][Full Text] [Related]
2. [Treatment failure in children with acute myelocytic leukemia: over 25-year experience of Polish Pediatric Leukemia/Lymphoma Study Group with four consecutive unified treatment protocols for childhood acute myelocytic leukemia].
Dłuzniewska A; Balwierz W; Balcerska A; Chybicka A; Kamieńska E; Karolczyk G; Karpińska-Derda I; Krawczuk-Rybak M; Kowalczyk JR; Lewandowska D; Maciejka-Kapuścińska L; Kołtano S; Malinowska I; Matysiak M; Mikołajczyk M; Mizia-Malarz A; Muszyńska-Rosłan K; Niedźwiedzki M; Pohorecka J; Sikorska-Fic B; Sobol G; Sońta-Jakimczyk D; Tomaszewska R; Urasiński T; Wachowiak J; Wieczorek M; Wójcik B; Wysocki M
Przegl Lek; 2010; 67(6):366-70. PubMed ID: 21344763
[TBL] [Abstract][Full Text] [Related]
3. Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.
Creutzig U; Ritter J; Zimmermann M; Reinhardt D; Hermann J; Berthold F; Henze G; Jürgens H; Kabisch H; Havers W; Reiter A; Kluba U; Niggli F; Gadner H
J Clin Oncol; 2001 May; 19(10):2705-13. PubMed ID: 11352963
[TBL] [Abstract][Full Text] [Related]
4. Advances in the First Line Treatment of Pediatric Acute Myeloid Leukemia in the Polish Pediatric Leukemia and Lymphoma Study Group from 1983 to 2019.
Czogała M; Balwierz W; Pawińska-Wąsikowska K; Książek T; Bukowska-Strakova K; Czogała W; Sikorska-Fic B; Matysiak M; Skalska-Sadowska J; Wachowiak J; Moj-Hackemer M; Kałwak K; Muszyńska-Rosłan K; Krawczuk-Rybak M; Grabowski D; Kowalczyk J; Maciejka-Kembłowska L; Irga-Jaworska N; Bobeff K; Młynarski W; Tomaszewska R; Szczepański T; Chodała-Grzywacz A; Karolczyk G; Mizia-Malarz A; Mycko K; Badowska W; Zielezińska K; Urasiński T; Urbańska-Rakus J; Ciebiera M; Chaber R; Bartoszewicz N; Wysocki M; Skoczeń S
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572762
[TBL] [Abstract][Full Text] [Related]
5. Development of treatment and clinical results in childhood AML in Austria (1993-2013).
Boztug H; Mühlegger N; Glogova E; Mann G; Urban C; Meister B; Schmitt K; Jones N; Attarbaschi A; Haas O; Strehl S; Lion T; Pötschger U; Fink FM; Gadner H; Dworzak M
Memo; 2014; 7(1):63-74. PubMed ID: 32288851
[TBL] [Abstract][Full Text] [Related]
6. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.
Creutzig U; Zimmermann M; Reinhardt D; Dworzak M; Stary J; Lehrnbecher T
J Clin Oncol; 2004 Nov; 22(21):4384-93. PubMed ID: 15514380
[TBL] [Abstract][Full Text] [Related]
7. Outcome of refractory and relapsed acute myeloid leukemia in children treated during 2005-2011 - experience of the Polish Pediatric Leukemia/Lymphoma Study Group (PPLLSG).
Skalska-Sadowska J; Wachowiak J; ; Skalska-Sadowska J; Wachowiak J; Zając-Spychała O; Niewiadomska-Wojnałowicz I; Januszkiewicz-Lewandowska D; Balwierz W; Pawińska-Wąsikowska K; Goździk J; Chybicka A; Potocka K; Krawczuk-Rybak M; Muszyńska-Rosłan K; Adamkiewicz-Drożyńska E; Maciejka-Kapuścińska L; Karolczyk G; Kowalczyk J; Wójcik B; Badowska W; Urasiński T; Ociepa T; Matysiak M; Sikorska-Fic B; Szczepański T; Tomaszewska R; Sobol G; Wieczorek M; Karpińska-Derda I
Contemp Oncol (Pozn); 2014; 18(1):48-53. PubMed ID: 24876821
[TBL] [Abstract][Full Text] [Related]
8. Treatment strategy and results in children treated on three Dutch Childhood Oncology Group acute myeloid leukemia trials.
Kardos G; Zwaan CM; Kaspers GJ; de-Graaf SS; de Bont ES; Postma A; Bökkerink JP; Weening RS; van der Does-van den Berg A; van Wering ER; Korbijn C; Hählen K
Leukemia; 2005 Dec; 19(12):2063-71. PubMed ID: 16107896
[TBL] [Abstract][Full Text] [Related]
9. Second Relapse of Pediatric Patients with Acute Myeloid Leukemia: A Report on Current Treatment Strategies and Outcome of the AML-BFM Study Group.
Rasche M; Steidel E; Zimmermann M; Bourquin JP; Boztug H; Janotova I; Kolb EA; Lehrnbecher T; von Neuhoff N; Niktoreh N; Mühlegger N; Sramkova L; Stary J; Walter C; Creutzig U; Dworzak M; Reinhardt D
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33672815
[TBL] [Abstract][Full Text] [Related]
10. Improved Outcome in Pediatric Acute Myeloid Leukemia: Progress With Hematopoietic Cell Transplantation.
Stankiewicz J; Styczynski J
Anticancer Res; 2022 Sep; 42(9):4499-4504. PubMed ID: 36039434
[TBL] [Abstract][Full Text] [Related]
11. Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials.
Creutzig U; Zimmermann M; Ritter J; Reinhardt D; Hermann J; Henze G; Jürgens H; Kabisch H; Reiter A; Riehm H; Gadner H; Schellong G
Leukemia; 2005 Dec; 19(12):2030-42. PubMed ID: 16304570
[TBL] [Abstract][Full Text] [Related]
12. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.
Creutzig U; Zimmermann M; Lehrnbecher T; Graf N; Hermann J; Niemeyer CM; Reiter A; Ritter J; Dworzak M; Stary J; Reinhardt D
J Clin Oncol; 2006 Sep; 24(27):4499-506. PubMed ID: 16983120
[TBL] [Abstract][Full Text] [Related]
13. [Improved results in the treatment of acute myeloid leukemia - Results of study AML-BFM-93 in East Germany with comparisons to the preceding studies AML-I-82 and AML-II-87].
Steinbach D; Dörffel W; Eggers G; Holfeld E; Kluba U; Krause I; Lauterbach I; Reiss T; Rieske K; Scharfe V; Schumacher R; Weigel H; Weinmann G; Zintl F; Hermann J
Klin Padiatr; 2001; 213(4):162-8. PubMed ID: 11528549
[TBL] [Abstract][Full Text] [Related]
14. Treating childhood acute myeloid leukaemia with the AML-BFM-83 protocol: experience in a developing country.
Chan LL; Abdel-Latif ME; Ariffin WA; Ariffin H; Lin HP
Br J Haematol; 2004 Sep; 126(6):799-805. PubMed ID: 15352983
[TBL] [Abstract][Full Text] [Related]
15. Consequent and intensified relapse therapy improved survival in pediatric AML: results of relapse treatment in 379 patients of three consecutive AML-BFM trials.
Sander A; Zimmermann M; Dworzak M; Fleischhack G; von Neuhoff C; Reinhardt D; Kaspers GJ; Creutzig U
Leukemia; 2010 Aug; 24(8):1422-8. PubMed ID: 20535146
[TBL] [Abstract][Full Text] [Related]
16. Treatment results of three consecutive German childhood AML trials: BFM-78, -83, and -87. AML-BFM-Group.
Ritter J; Creutzig U; Schellong G
Leukemia; 1992; 6 Suppl 2():59-62. PubMed ID: 1578943
[TBL] [Abstract][Full Text] [Related]
17. Survival Following Relapse in Children with Acute Myeloid Leukemia: A Report from AML-BFM and COG.
Rasche M; Zimmermann M; Steidel E; Alonzo T; Aplenc R; Bourquin JP; Boztug H; Cooper T; Gamis AS; Gerbing RB; Janotova I; Klusmann JH; Lehrnbecher T; Mühlegger N; Neuhoff NV; Niktoreh N; Sramkova L; Stary J; Waack K; Walter C; Creutzig U; Dworzak M; Kaspers G; Kolb EA; Reinhardt D
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34066095
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and treatment outcomes of peripheral T-cell lymphoma in children. A current data report from Polish Pediatric Leukemia/Lymphoma Study Group (PPLLSG).
Maciejka-Kemblowska L; Chaber R; Wrobel G; Maldyk J; Kozlowska M; Kulej D; Kazanowska B; Bubala H; Dembowska-Baginska B; Karolczyk G; Koltan A; Wyrobek E
Adv Med Sci; 2016 Sep; 61(2):311-316. PubMed ID: 27254421
[TBL] [Abstract][Full Text] [Related]
19. Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78. AML-BFM Study Group.
Creutzig U; Ritter J; Schellong G
Blood; 1990 May; 75(10):1932-40. PubMed ID: 2186819
[TBL] [Abstract][Full Text] [Related]
20. Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group.
Coenen EA; Zwaan CM; Reinhardt D; Harrison CJ; Haas OA; de Haas V; Mihál V; De Moerloose B; Jeison M; Rubnitz JE; Tomizawa D; Johnston D; Alonzo TA; Hasle H; Auvrignon A; Dworzak M; Pession A; van der Velden VH; Swansbury J; Wong KF; Terui K; Savasan S; Winstanley M; Vaitkeviciene G; Zimmermann M; Pieters R; van den Heuvel-Eibrink MM
Blood; 2013 Oct; 122(15):2704-13. PubMed ID: 23974201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
